Dexrazoxane Intravenous and Insulin detemir Subcutaneous
Determining the interaction of Dexrazoxane Intravenous and Insulin detemir Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Insulin glargine
- Dexrazoxane Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Dexrazoxane Intravenous-Insulin Glargine (U-100) Vials
- Dexrazoxane Intravenous-Insulin Glargine (U-300) Pens
- Dexrazoxane Intravenous-Insulin glargine and lixisenatide
- Dexrazoxane Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Insulin detemir Subcutaneous-Dextenza Insert
- Insulin detemir Subcutaneous-Dextenza intraocular
- Insulin detemir Subcutaneous-Dextran 40
- Insulin detemir Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin detemir Subcutaneous-Dextran 75
- Insulin detemir Subcutaneous-Dextran high molecular weight